Floatz logo

Modafinil

Sleep Disorders

Duke UniversitySmall moleculePhase 3Active
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

14 Active assets in the Sleep Disorders cohort.

View all 36

Same molecule, other indications

Modafinil is also rated in:

schizoaffective disorderDormant
BB
Indicative ·
70 / 100
View asset →
schizophreniaDormant
BB
Indicative ·
66 / 100
View asset →
schizophreniform disorderDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →